Novo Nordisk
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
NOVO | CO
Overview
Corporate Details
- ISIN(s):
- DK0062498333 (+1 more)
- LEI:
- 549300DAQ1CVT6CXN342
- Country:
- Denmark
- Address:
- Novo Alle 1, 2880 Bagsværd
- Website:
- https://www.novonordisk.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novo Nordisk is a global healthcare company that discovers, develops, and manufactures innovative biological medicines and therapeutic devices. With a focus on driving change to defeat serious chronic diseases, the company's primary treatment areas include diabetes, obesity, and rare blood and endocrine disorders. Leveraging over 90 years of innovation, Novo Nordisk provides pharmaceutical products and services to patients worldwide, aiming to make its treatments accessible and improve health outcomes.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Novo Nordisk and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-10 07:00 |
Regulatory News Service
|
English | 11.2 KB | |
| 2025-09-10 07:00 |
Earnings Release
|
English | 151.5 KB | |
| 2025-08-19 13:37 |
Director's Dealing
|
English | 17.4 KB | |
| 2025-08-19 13:37 |
Director's Dealing
|
English | 144.5 KB | |
| 2025-08-12 14:25 |
Director's Dealing
|
English | 144.4 KB | |
| 2025-08-12 14:25 |
Director's Dealing
|
English | 17.4 KB | |
| 2025-08-08 15:15 |
Director's Dealing
|
English | 17.4 KB | |
| 2025-08-08 15:15 |
Director's Dealing
|
English | 144.5 KB | |
| 2025-08-07 17:30 |
Director's Dealing
|
English | 159.1 KB | |
| 2025-08-07 17:30 |
Director's Dealing
|
English | 30.5 KB | |
| 2025-08-06 07:30 |
Earnings Release
|
English | 1.4 MB | |
| 2025-08-06 07:30 |
Earnings Release
|
English | 11.9 KB | |
| 2025-07-29 13:35 |
Board/Management Information
|
English | 12.0 KB | |
| 2025-07-29 13:35 |
Board/Management Information
|
English | 176.8 KB | |
| 2025-07-29 13:01 |
Earnings Release
|
English | 167.4 KB |
Automate Your Workflow. Get a real-time feed of all Novo Nordisk filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Novo Nordisk via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
